Despite the increased prevalence of insulin pump use over the past 2 decades, there have been few improvements in uptake of the devices among patients who are Black or who come from lower socioeconomic levels.
A recent study shows few improvements in the ethnic, racial, and socioeconomic inequities in insulin pump use among youth with type 1 diabetes (T1D), building on previous studies with similar findings.
Researchers presented the study at ENDO 2022, the annual meeting of the Endocrine Society.
The serial cross-sectional analysis used data from population-based SEARCH for Diabetes in Youth Study to determine whether inequities in the use of insulin pumps for T1D have increased or diminished over time.
Changes over time in insulin pump use for T1D were evaluated for participants less than 20 years old by racial and ethnic group, health insurance, household income, and level of parental education across 4 time periods: 2001-2005; 2006-2010; 2011-2015; and 2016-2019.
Models used were adjusted for other predictors including age at each visit, diabetes duration, sex, and clinic site in the estimation of probability of insulin pump use.
Overall prevalence of insulin pump use increased to 58.3% in 2016-2019 from 30% in 2001-2006. And Hispanic patients saw some improvement: the adjusted odds ratio (OR) for pump use in this group was 0.08 (95% CI, 0.01-0.63) in 2001-2006 and 0.65 (95% CI, 0.48-0.87) in 2016-2019, a statistically significant improvement (P = .004).
However, when looking at the data by race and income and other factors, and comparing the results with Whites, large gaps became evident as no improvements were seen throughout any of the time periods in this study.
The OR for Black and other races was 0.28 (95% CI, 0.21-0.37; P = .864) and 0.43 (95% CI; 0.26-0.71; P =.439) and did not change through the course of the study.
Adjusted OR for pump use in those with some high school/high school degree and those with some college was 0.38 (95% CI; 0.30-0.48; P = .160) and 0.69 (95% CI; 0.57-0.82; P = .894) and did not change over time, compared with those whose parents had a a bachelor’s degree or more.
Compared with those with private health insurance, those with public health insurance had an OR for pump use of 0.84 (0.68-1.03; P = .815)
Compared with those with an annual household income of >$75,000, those with an income of <$25,000 $25,000-$49,000, and $50,000-$74,000 had an OR for pump use of 0.43 (95% CI, 0.34-0.54; P = .937), 0.57 (95% CI; 0.46-0.71; P = .870), and 0.80 (95% CI; 0.65-0.97; P = .821) respectively,
The results show that there have been few improvements in the ethnic, racial, and socioeconomic inequities in insulin pump use among youth with T1D over the past 2 decades.
“Studies that evaluate barriers or test interventions to improve technology access are needed to address the persistent inequities in diabetes care,” wrote the authors.
Reference
Everett E, Wright D, Williams A, et al. Assessing longitudinal disparities in insulin pump use among youth with type 1 diabetes. Presented at: ENDO 2022. June 14, 2022. Atlanta, Georgia.
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Panel Addresses Minority Physician Shortage, Maternal Health at Senate Committee Hearing
May 15th 2024The senate hearing held by the US Senate Committee on Health, Education, Labor, and Pensions, led by Sen. Bernie Sanders (I, Vermont), chairman of the committee, and ranking member Sen. Bill Cassidy, MD, (R, Louisiana), addressed the critical issue of physician and health care worker shortages, as well as the maternal health crisis, in the US.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
A new study highlights significant disparity in reimbursement rates across states between hospitals and Medicare; the first patient to receive a genetically modified pig kidney has died; research examines outcomes of over 500 patients receiving medication abortion pills by mail.
Read More